Walgreens just announced the launch of their Center for Health & Wellbeing Research www.walgreens.com/research, a website featuring more than 50 Walgreens outcome studies completed in the past six years.
Areas of research include access to care and patient experience, adherence and clinical outcomes, digital health and member engagement, healthcare costs, HIV and specialty pharmacy vaccinations, and much more.
Visitors to the site will find summaries, links, and original documents related to company research reports and studies that have been published in peer-reviewed medical and healthcare publications, as well as presented at scientific and industry conferences.
Walgreens has been and continues to work with academic institutions on their research. These institutions include Johns Hopkins Medicine www.hopkinsmedicine.org, Johns Hopkins Bloomberg School of Public Health https://www.jhsph.edu , Scripps Translational Science Institute https://www.stsiweb.org, University of California, San Francisco-School of Pharmacy https://pharmacy.ucsf.edu, and the University of Chicago Medicine www.uchospitals.edu.
These institutions provide guidance, specialized expertise, and industry insights that contribute to the Walgreens outcomes research agenda. Researchers from Walgreens and the institutions actively collaborate on a variety of research studies. The research team is led by a team of more than 25 Walgreens health services researchers composed of clinicians, statisticians, public health practitioners, actuaries, and data scientists.
For example, researchers in a study from Walgreens and Inovalon www.inovalon.com, examined Walgreens Connected Care Cystic Fibrosis (CF) program to determine the effectiveness of the program as compared to a matched sample of control patients.
The study found that CF patients have better outcomes when enrolled in a pharmacy-based comprehensive therapy management program. The study was presented at the 30th Annual North American Cystic Fibrosis Conference held in Orlando.